Fund Holdings — Saturn V Capital Management LP

Total Portfolio Value:
$261.25M
Total Bought:
$58.36M
Total Sold:
$93.18M
Net Transaction:
-$34.82M
Notable People:
Xiaoying (Nmn) Tian, Douglas Kevin Edwards
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Cytokinetics, Incorporated(CYTK)495,168448,144-47,024$14.59M$37.42M14.32%+$22.83M
Crinetics Pharmaceuticals In1,126,579787,132-339,447$33.50M$28.01M10.72%-$5.50M
Kalvista Pharmaceuticals Inc1,810,2461,807,563-2,683$17.43M$22.14M8.48%+$4.71M
argenx SEADR(ARGX)10,07451,175+41,101$4.95M$19.47M7.45%+$14.52M
Cymabay Therapeutics Inc1,124,459750,250-374,209$16.77M$17.72M6.78%+$955.2K
Ascendis Pharma A/SADR(ASND)112,473131,759+19,286$10.53M$16.60M6.35%+$6.06M
Amylyx Pharmaceuticals, Inc.(AMLX)886,1431,099,268+213,125$16.23M$16.18M6.19%-$44.1K
Anaptysbio Inc577,101664,276+87,175$10.36M$14.23M5.45%+$3.86M
BioMarin Pharmaceutical Inc.(BMRN)109,685119,188+9,503$9.70M$11.49M4.40%+$1.79M
Syndax Pharmaceuticals, Inc.(SNDX)807,969518,799-289,170$11.73M$11.21M4.29%-$520.5K
Merus N V40,066389,333+349,267$944.8K$10.71M4.10%+$9.76M
Iteos Therapeutics Inc994,756828,232-166,524$10.89M$9.07M3.47%-$1.82M
Apellis Pharmaceuticals Inc
COM
0142,927+142,927$0$8.56M3.27%+$8.56M
Biogen Inc.(BIIB)64,67632,469-32,207$16.62M$8.40M3.22%-$8.22M
Astria Therapeutics Inc1,219,093990,663-228,430$9.09M$7.61M2.91%-$1.49M
Morphic Hldg Inc136,743212,343+75,600$3.13M$6.13M2.35%+$3.00M
Cogent Biosciences, Inc.(COGT)1,775,415756,681-1,018,734$17.31M$4.45M1.70%-$12.86M
Disc Medicine, Inc.(IRON)064,784+64,784$0$3.74M1.43%+$3.74M
Amicus Therapeutics Inc
COM
0199,973+199,973$0$2.84M1.09%+$2.84M
Alnylam Pharmaceuticals, Inc.(ALNY)010,327+10,327$0$1.98M0.76%+$1.98M
Phathom Pharmaceuticals, Inc.(PHAT)0160,075+160,075$0$1.46M0.56%+$1.46M
Jasper Therapeutics, Inc.(JSPR)1,387,0151,386,215-800$970.9K$1.09M0.42%+$122.8K
Ambrx Biopharma Inc052,781+52,781$0$751.6K0.29%+$751.6K
BIOCRYST PHARMACEUTICALS INCCOM(BCRX)982,4580-982,458$6.96M$0—-$6.96M
HORIZON THERAPEUTICS PUB LSHS111,0450-111,045$12.85M$0—-$12.85M
SAREPTA THERAPEUTICS INCCOM(SRPT)118,4010-118,401$14.35M$0—-$14.35M
Page 1 of 1
Saturn V Capital Management LP — 13F Holdings — Q4 2023 | TickerTrail